Abstract

Background New Wenshen Shengjing Decoction (NWSSJD), a traditional Chinese compound medicine, has significant effect on spermatogenesis disorder and can significantly improve sperm quality. Many components in NWSSJD can induce epigenetic modifications of different types of cells. It is not yet known whether they can cause epigenetic modifications in sperm or early embryos. Objective This study investigated the effect of NWSSJD on mouse early embryonic development and its regulation of H3K4me3 in mouse sperm and early embryos. Methods Spermatogenesis disorder was induced in male mice with CPA (cyclophosphamide). NWSSJD was administrated for 30 days. Then, the male mice were mated with the female mice with superovulation, and the embryo degeneration rate of each stage was calculated. Immunofluorescence staining was used to detect the expression of H3K4me3 in sperm and embryos at various stages. Western blotting was performed to detect methyltransferase SETD1B expression. The expressions of development-related genes (OCT-4, NANOG, and CDX2) and apoptosis-related genes (BCL-2 and p53) were measured with qRT-PCR. Results Compared with the CPA group, NWSSJD significantly reduced the H3K4me3 level in sperms, significantly increased the number of normal early embryos (2-cell embryos, 3-4-cell embryos, 8-16-cell embryos, and blastocysts) per mouse, and reduced the degeneration rate of the embryos. The expression levels of H3K4me3 and methyltransferase SETD1B in early embryos were significantly elevated by NWSSJD. Additionally, NWSSJD significantly promoted BCL-2 expression, while reducing p53 expression, thus inhibiting embryonic cell apoptosis. Moreover, the expressions of development-related genes OCT-4 and CDX2 were significantly increased by NWSSJD, but NANOG expression had no significant difference. Conclusion NWSSJD may promote early embryonic development possibly by maintaining low H3K4me3 levels in sperms and normal H3K4me3 modification in early embryos and by inhibiting embryonic cell apoptosis.

Highlights

  • The New Wenshen Shengjing Decoction (NWSSJD) is a traditional Chinese compound medicine and has been widely used to treat spermatogenesis disorders in males [1,2,3,4,5]

  • The results indicate that NWSSJD is basically nontoxic to mice

  • Our study found that the NWSSJD+CPA group significantly increased the H3K4me3 modification level and the expression of OCT-4, NANOG, and Bcl-2 genes in embryos than the CPA group

Read more

Summary

Introduction

The New Wenshen Shengjing Decoction (NWSSJD) is a traditional Chinese compound medicine and has been widely used to treat spermatogenesis disorders in males [1,2,3,4,5]. NWSSJD has a significant antioxidant effect [2], BioMed Research International which can protect the testis and epididymis from oxidative damage by increasing the activities of GSH-Px (glutathione peroxidase) and CAT (catalase) in mature sperm and can significantly improve the activity of mitochondria in sperms [3]. It plays an important therapeutic role in oligoasthenospermia. New Wenshen Shengjing Decoction (NWSSJD), a traditional Chinese compound medicine, has significant effect on spermatogenesis disorder and can significantly improve sperm quality. NWSSJD may promote early embryonic development possibly by maintaining low H3K4me levels in sperms and normal H3K4me modification in early embryos and by inhibiting embryonic cell apoptosis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call